Continued targeting of androgen receptor signalling: a rational and efficacious therapeutic strategy in metastatic castration-resistant prostate cancer

被引：3
|
作者：
Bianchini, Diletta [1 ]
de Bono, Johann S.
机构：
[1] Inst Canc Res, Med Sect, Sutton, Surrey, England
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
MITOXANTRONE PLUS PREDNISONE; I CLINICAL-TRIAL; ABIRATERONE ACETATE; ANTITUMOR-ACTIVITY; CYP17; DOCETAXEL; PROGRESSION; INHIBITOR; MECHANISM; KETOCONAZOLE;
D O I：
10.1016/S0959-8049(11)70164-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S189 / S194
页数：6
相关论文
共 50 条
  • [1] Targeting the androgen receptor in metastatic castration-resistant prostate cancer
    Aragon-Ching, Jeanny B.
    FUTURE ONCOLOGY, 2014, 10 (03) : 329 - 332
  • [2] Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
    Schalken, Jack
    Fitzpatrick, John M.
    BJU INTERNATIONAL, 2016, 117 (02) : 215 - 225
  • [3] Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC)
    Tsao, Che-Kai
    Galsky, Matthew D.
    Small, Alexander C.
    Yee, Tiffany
    Oh, William K.
    BJU INTERNATIONAL, 2012, 110 (11) : 1580 - 1588
  • [4] Improved Therapeutic Targeting of the Androgen Receptor: Rational Drug Design Improves Survival in Castration-Resistant Prostate Cancer
    Lim, Ai Chiin
    Attard, Gerhardt
    CURRENT DRUG TARGETS, 2013, 14 (04) : 408 - 419
  • [5] Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer
    Sharp, Adam
    Welti, Jonathan
    Blagg, Julian
    de Bono, Johann S.
    CLINICAL CANCER RESEARCH, 2016, 22 (17) : 4280 - 4282
  • [6] Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer
    Reichert, Zachery R.
    Hussain, Maha
    CANCER JOURNAL, 2016, 22 (05): : 326 - 329
  • [7] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
  • [8] Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
    Graham, Laura
    Schweizer, Michael T.
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [9] Putting the brakes on continued androgen receptor signaling in castration-resistant prostate cancer
    Eichholz, Andrew
    Ferraldeschi, Roberta
    Attard, Gerhardt
    de Bono, Johann S.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 360 (1-2) : 68 - 75
  • [10] Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Marin-Aguilera, Mercedes
    Lolli, Cristian
    Schepisi, Giuseppe
    Maugeri, Antonio
    Wingate, Anna
    Farolfi, Alberto
    Casadio, Valentina
    Medina, Ana
    Puente, Javier
    Mendez Vidal, Ma Jose
    Morales-Barrera, Rafael
    Villa-Guzman, Jose C.
    Hernando, Susana
    Rodriguez-Vida, Alejo
    Gonzalez-del-Alba, Aranzazu
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    EUROPEAN UROLOGY, 2019, 75 (03) : 368 - 373
12345